Barclays Hikes Atlassian Price Target to $112 on ARR
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
Compare volatility and returns in retirement index funds to strike a balance between potential growth and risk control for sustainable withdrawals.
24,638 articlesBarclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
Income-focused investors flock to AGNC for its big dividend, but the real driver of long-term value is its net intere...
Rumors of a SpaceX public offering sparked a dramatic surge in crypto derivatives on Hyperliquid, with the SPCX perpe...
South Korea’s memory-chip giant SK Hynix plans a Nasdaq debut with a roughly $29 billion offer, aiming to test if AI-...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A shifting geopolitical landscape intersects AI, policy, and crypto. This article breaks down what Anthropic's used I...
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Willdan stock skyrocketing has investors buzzing as one large fund sold about $7.74 million worth of shares. This art...
What would a new Fed chair do if inflation stayed stubborn while growth slowed? This article imagines Chair Kevin War...
Kevin Warsh chairs his first FOMC meeting as crypto markets brace for policy clarity. Bitcoin steadies near 66,000 wh...
U.S. equities closed the second quarter with a double‑digit rally, led by AI-driven tech names. Yet analysts warn tha...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...